Make your money go further for just 25p per day

AIM IHT

A tale of 2 investment managers

Sustainability

There were positive trading updates from companies covered here, including a couple of relative newcomers to AIM, as well as two investment managers commanding very different valuations. (Free to read)


Cambridge Cognition: major new pharma client

Cambridge Cognition (AIM: COG), which develops and markets digital solutions to assess brain health, has been awarded contracts for two clinical trials by a top 20 pharmaceutical company to assess the pro-cognitive effects of a new drug in schizophrenia. Together the contracts are worth £700,000 over two years.

This is the second pharmaceutical client to award Cambridge Cognition major contracts for cognitive assessments for schizophrenia in…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Cambridge Cognition

Positive update and plenty of visibility

21/07/2022 · Company Insights

This digital health technology company developing solutions to assess brain health, has announced a positive trading update. Forecasts…


Victoriana going cheap

29/03/2022 · Company Insights

An entertainment business covered here, with its roots in the Victorian era, has just reported encouraging…


More on Impax Asset Management

Atlantis rises from the depths

08/07/2022 · Company Insights

Shares in a sustainable energy specialist soar on news of new government support. Elsewhere shares in…


Quality company delivers | Inflationary tales

01/06/2022 · Company Insights

Excellent results from one of AIM’s high-quality companies bizarrely saw their shares fall, while elsewhere an…


More on Premier Miton Group

A tale of 2 investment managers

11/01/2022 · Company Insights

There were positive trading updates from companies covered here, including a couple of relative newcomers to…


A move to Bonkers Bargain

08/12/2021 · Company Insights

One small company covered here is leading the way in delivering insights in neuroscience, yet the…


More on Quartix Technologies

Can this company return to past glories?

27/07/2022 · Company Insights

A well-established AIM company covered here is currently conducting an in-depth of review of some of…


Scientific excellence

24/03/2022 · Company Insights

An acquirer of companies in the scientific instruments sector has reported yet more impressive results. There…


More on Shoe Zone

A tale of 2 investment managers

11/01/2022 · Company Insights

There were positive trading updates from companies covered here, including a couple of relative newcomers to…


​Coronavirus impact: 28 Oct – volatility fuels booming returns

28/10/2020 · Company Insights

An online trading platform featured here has done nicely from the heightened stock market volatility and…


More on Tortilla Mexican Grill

A tale of 2 investment managers

11/01/2022 · Company Insights

There were positive trading updates from companies covered here, including a couple of relative newcomers to…


AIM new arrivals October 2021

03/11/2021 · Company Insights

October proved to be a big month for resources listings on AIM, including a tungsten and…


More Company Insights

This 125-year-old is in great shape

Where a 7% dividend yield hides a multitude of issues

AIM new arrivals and leavers July 2022

03/08/2022 · Fiinu · LifeSafe Holdings

Sign-up to our free email updates

SIGN UP